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The epidermal differentiation program is regulated at
several levels including signaling pathways, lineage-
specific transcription factors, and epigenetic regulators
that establish well-coordinated process of terminal
differentiation resulting in formation of the epidermal
barrier. The epigenetic regulatory machinery operates
at several levels including modulation of covalent
DNA/histone modifications, as well as through
higher-order chromatin remodeling to establish long-
range topological interactions between the genes and
their enhancer elements. Epigenetic regulators exhibit
both activating and repressive effects on chromatin in
keratinocytes (KCs): whereas some of them promote
terminal differentiation, the others stimulate prolifera-
tion of progenitor cells, as well as inhibit premature
activation of terminal differentiation-associated genes.
Transcription factor-regulated and epigenetic mechan-
isms are highly connected, and the p63 transcription
factor has an important role in the higher-order
chromatin remodeling of the KC-specific gene loci
via direct control of the genome organizer Satb1 and
ATP-dependent chromatin remodeler Brg1. However,
additional efforts are required to fully understand the
complexity of interactions between distinct transcrip-
tion factors and epigenetic regulators in the control of
KC differentiation. Further understanding of these
interactions and their alterations in different patholo-
gical skin conditions will help to progress toward the
development of novel approaches for the treatment of
skin disorders by targeting epigenetic regulators and
modulating chromatin organization in KCs.
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INTRODUCTION
Establishment of the functional epidermal barrier is one of the
major goals of the epidermal differentiation program, which
includes a tightly regulated process of keratinocyte (KC)
proliferation, terminal differentiation, apoptosis, and
shedding. The program of epidermal development and KC
differentiation is governed by coordinated involvement of
several transcription factors (p63, AP-1, Klf4, Arnt, and so
on), signaling pathways (Wnt, Bmp, Hedgehog, EGF, Notch,
FGF, and so on) and epigenetic regulators (DNA/histone-
modifying enzymes, Polycomb genes, higher-order and ATP-
dependent chromatin remodelers, and non-coding RNAs) that
control expression of lineage-specific genes (reviewed in
Botchkarev et al., 2012; Frye and Benitah, 2012; Perdigoto
et al., 2014).
MOLECULAR CONTROL OF CELL DIFFERENTIATION
The p63 transcription factor operates as master regulator of
this program, and subsequently and stage-dependently
induces in the epidermal progenitor cells expression of several
groups of genes encoding the essential components of the
cytoskeleton (keratins 5 and 14), cell adhesion molecules
(P-cadherin, integrin-a3, Perp, dystonin, and so on), cell
matrix regulators (Fras-1), transcription factors (AP-2g, IKKa,
IRF6), and epigenetic regulators (Satb1, Brg1) involved in the
control of epidermal differentiation (Koster and Roop, 2007;
Vanbokhoven et al., 2011; Botchkarev and Flores, 2014).
Genetic p63 ablation in mice results in the failure of
stratification of the epidermis and other squamous epithelia,
lack of the formation of epidermal appendages (hair follicles,
glands, teeth) and in severe abnormalities in the development
of limbs and external genitalia (Mills et al., 1999; Yang et al.,
1999; Ince et al., 2002). Moreover, heterozygous mutations in
the human p63 gene underlie several ectodermal dysplasia
syndromes, also characterized by abnormalities in the
development of digits, teeth, hairs, nails, and sweat glands
(reviewed in Rinne et al., 2007; Koster, 2010).
p63 has multiple isoforms, including TAp63 and DNp63,
which show distinct, although partially overlapping, roles in
the control of epidermal differentiation and stratification
(Koster and Roop, 2007; Vanbokhoven et al., 2011;
Botchkarev and Flores, 2014). The DNp63 isoform is more
abundant in the epidermis compared with TAp63, is strongly
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expressed in basal epidermal KCs, and is markedly
downregulated in the spinous layer (Romano et al., 2012).
DNp63 has a major role in mediating the effects of p63 on
epidermal development, whereas TAp63 protects KCs from
senescence and suppress tumorigenesis in postnatal epidermis
(Guo et al., 2009; Romano et al., 2012).
EPIGENETIC MECHANISMS
Epigenetic mechanisms have an important role in the control
of cellular functions in living organisms and are considered as
a driving force of the phenotypic plasticity and evolutionary
adaptation (Feinberg, 2007). Epigenetic regulatory machinery
operates at several levels including modulation of covalent
DNA/histone modifications, as well as through higher-order
chromatin remodeling to establish long-range topological
interactions between the genes and their enhancer elements
in three-dimensional (3D) nuclear space (Ho and Crabtree,
2010; Bickmore and van Steensel, 2013).
Epigenetic regulators exhibit both activating and repressive
effects on chromatin in KCs: histone demethylase Jmjd3, ATP-
dependent chromatin remodeler Brg1, and genome organizer
Satb1 promote terminal KC differentiation, whereas DNA
methyltransferase (DNMT1), histone deacetylases (HDAC1/2),
and polycomp components (Bmi1 and Ezh1/2) stimulate
proliferation of progenitor cells via repression of the genes
encoding cell-cycle inhibitors, as well as inhibit premature
activation of terminal differentiation-associated genes
(reviewed in Eckert et al., 2011; Botchkarev et al., 2012;
Frye and Benitah, 2012; Perdigoto et al., 2014). In addition,
epigenetic regulators might control expression of transcription
factors in KCs via formation of the active or repressive
local chromatin structure at their promoter regions: for
instance, p63 expression in KCs is inhibited by histone
methyltransferase Setd8 and HDAC2, which interfere with
the DNp63-regulated gene expression program in KCs
(LeBoeuf et al., 2010; Driskell et al., 2012).
The KC nucleus is a complex and highly compartmentalized
organelle, whose 3D organization undergoes major changes
during terminal differentiation in the epidermis (Gdula et al.,
2013). The process of terminal differentiation in epidermal
cells is accompanied by sequential changes of gene
expression in the keratin type I/II loci, followed by the onset
of expression of the epidermal differentiation complex (EDC)
locus genes encoding the essential components of the
epidermal barrier (Fuchs and Horsley, 2011).
Our recent studies revealed that transcription factor-depen-
dent and epigenetic regulatory mechanisms in KCs are highly
connected, and p63 has a hitherto unrecognized role in the
higher-order chromatin remodeling of the EDC locus via direct
control of the genome organizer Satb1 and ATP-dependent
chromatin remodeler Brg1 (Fessing et al., 2011; Mardaryev
et al., 2014).
Among different epigenetic regulators, Satb1 has a unique
role in the execution of lineage-specific gene expression
programs by integrating high-order chromatin organization
with regulation of gene expression (Cai et al., 2006). Satb1
binds specialized DNA regions with an ATC-sequence context
and folds chromatin into loops involving tissue-specific gene
loci (TH2-cytokine and MHC class I loci, globin locus, and so
on), as well as targets chromatin remodelers/transcription
factors to gene loci (Kumar et al., 2007). Satb1 also
contributes to the progression of tumors and promotes
reprogramming of the genome of breast cancer cells towards
metastasis (Kohwi-Shigematsu et al., 2013).
Satb1 is expressed in basal epidermal KCs and promotes cell
differentiation via establishment of specific conformation of
the EDC locus, whereas its ablation in mice results in the
marked elongation of the EDC central domain associated with
alterations in expression of the EDC genes and in epidermal
morphology (Fessing et al., 2011).
ATP-dependent chromatin remodeler Brg1, on the other
hand, promotes developmentally regulated relocation of the
EDC locus from the nuclear periphery towards nuclear interior
into the compartment enriched by nuclear speckles, which is
associated with marked increase in expression of the EDC
genes (Mardaryev et al., 2014). Importantly, conditional
ablation of Brg1 in the epidermis results in failure to form a
functional barrier, thus partially resembling the phenotype of
p63 knock-out mice (Indra et al., 2005). These data suggest
that chromatin remodeling genes represent a novel cohort of
p63 targets that mediate its effects on execution of lineage-
specific gene expression program in KCs (Botchkarev et al.,
2012; Fessing, 2014).
CONCLUSIONS AND FUTURE DIRECTIONS
However, additional efforts are required to fully understand
the complexity of interactions between distinct transcription
factors and epigenetic regulatory machinery in the control of
epidermal development, regeneration, and stem cell activity.
Recently, a number of molecules that are capable of modulat-
ing distinct components of the epigenetic machinery have
been developed, and some of them are already approved for
treatment of the distinct neoplastic conditions or under clinical
trials (Heightman, 2011). Thus, understanding of epigenetic
mechanisms controlling epidermal differentiation and skin
stem cell activity and their alterations in different
pathological skin conditions will help to develop a novel
cohort of epigenetic drugs for the treatment of skin disorders.
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